FDA approves new drug for osteoporosis
On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at high risk of fractures.…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
